Global Chimeric Antibody Market Growth (Status and Outlook) 2025-2031

Global Chimeric Antibody Market Growth (Status and Outlook) 2025-2031

The global Chimeric Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Chimeric antibody is the first genetically engineered antibody to be produced successfully. It is made by splicing the V region gene of mouse antibody and the C region gene of human antibody into chimeric gene, and then inserting the vector, transfecting the antibody molecule expressed in myeloma tissue. Because it reduces the murine component, it reduces the adverse reactions caused by murine antibody and helps to improve the curative effect.

United States market for Chimeric Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Chimeric Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Chimeric Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Chimeric Antibody players cover Creative-Biolabs, Biotem, OmniAb Technology, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Chimeric Antibody Industry Forecast” looks at past sales and reviews total world Chimeric Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Chimeric Antibody sales for 2025 through 2031. With Chimeric Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antibody industry.

This Insight Report provides a comprehensive analysis of the global Chimeric Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Chimeric Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chimeric Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:
IgG
IgM
IgA
Others

Segmentation by Application:
Hospital
Scientific Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative-Biolabs
Biotem
OmniAb Technology

Please note: The report will take approximately 2 business days to prepare and deliver.